Residues in the HIV-1 Capsid Assembly Inhibitor Binding Site Are Essential for Maintaining the Assembly-competent Quaternary Structure of the Capsid Protein
Open accessThe DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.
Abstract
Morphogenesis of infectious HIV-1 involves budding of immature virions followed by proteolytic disassembly of the Gag protein shell and subsequent assembly of processed capsid proteins (CA) into the mature HIV-1 core. The dimeric interface between C-terminal domains of CA (C-CA) has been shown to be important for both immature and mature assemblies. We previously reported a CA-binding peptide (CAI) that blocks both assembly steps in vitro. The three-dimensional structure of the C-CA/CAI complex revealed an allosteric effect of CAI that alters the C-CA dimer interface. Based on this structure, we now investigated the phenotypes of mutations in the binding pocket. CA variants carrying mutations Y169A, L211A, or L211S had a reduced affinity for CAI and were unable to form mature-like particles in vitro. These mutations also blocked morphological conversion to mature virions in tissue culture and abolished infectivity. X-ray crystallographic analyses of the variant C-CA domains revealed that these alterations induced the same allosteric change at the dimer interface observed in the C-CA/CAI complex. These results point to a role of key interactions between conserved amino acids in the CAI binding pocket of C-CA in maintaining the correct conformation necessary for mature core assembly.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The CA-CTD appeared as dimers similar to published dimeric crystal structures of the CA-CTD [26].”
From Retrovirus maturation-an extraordinary structural transformation (2016) · cites this paper as [26]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coot : model-building tools for molecular graphics
Emsley, P., & Cowtan, K. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904019158 · Cited by 30,571
Clustal W and Clustal X version 2.0
Larkin, M. A., Blackshields, G., Brown, N. P., Chenna, R., McGettigan, P. A., McWilliam, H., Valentin, F., Wallace, I. M., Wilm, A., Lopez, R., et al. (2007) · Bioinformatics · doi:10.1093/bioinformatics/btm404 · Cited by 28,358
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
The CCP4 suite: programs for protein crystallography
Collaborative Computational Project, N. 4. (1994) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444994003112 · Cited by 17,270
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., & Martin, M. A. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,834
Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections
Lennette, E. H., Lennette, D. A., & Lennette, E. T. (1989) · Virtual Defense Library (Ministerio de Defensa) · Cited by 2,353
Assembly and Analysis of Conical Models for the HIV-1 Core
Ganser, B. K., Li, S., Klishko, V. Y., Finch, J. T., & Sundquist, W. I. (1999) · Science · doi:10.1126/science.283.5398.80 · Cited by 671
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein
Gamble, T. R., Yoo, S., Vajdos, F. F., von Schwedler, U. K., Worthylake, D. K., Wang, H., McCutcheon, J. P., Sundquist, W. I., & Hill, C. P. (1997) · Science · doi:10.1126/science.278.5339.849 · Cited by 598
Structural basis for targeting HIV-1 Gag proteins to the plasma membrane for virus assembly
Saad, J. S., Miller, J., Tai, J., Kim, A., Ghanam, R. H., & Summers, M. F. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0602818103 · Cited by 545
Cited by
HIV-1 assembly, budding, and maturation
Sundquist, W. I., & Krausslich, H.-G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006924 · Cited by 814
X-Ray Structures of the Hexameric Building Block of the HIV Capsid
Pornillos, O., Ganser-Pornillos, B. K., Kelly, B. N., Hua, Y., Whitby, F. G., Stout, C. D., Sundquist, W. I., Hill, C. P., & Yeager, M. (2009) · Cell · doi:10.1016/j.cell.2009.04.063 · Cited by 523
“Previous studies have suggested conformational plasticity in the tertiary fold of the CTD (Alcaraz et al., 2007; Bartonova et al., 2008; Berthet-Colominas et al., 1999; Bhattacharya et al., 2008; Ivanov et al., 2007; Ternois et al., 2005; Wong et al., 2008), and this flexibility is also evident in…”
BackgroundResultInfluentialAn atomic model of HIV-1 capsid-SP1 reveals structures regulating assembly and maturation
Schur, F. K. M., Obr, M., Hagen, W. J. H., Wan, W., Jakobi, A. J., Kirkpatrick, J. M., Sachse, C., Kräusslich, H.-G., & Briggs, J. A. G. (2016) · Science · doi:10.1126/science.aaf9620 · Cited by 415
Atomic-level modelling of the HIV capsid
Pornillos, O., Ganser-Pornillos, B. K., & Yeager, M. (2011) · Nature · doi:10.1038/nature09640 · Cited by 372
Structure and assembly of immature HIV
Briggs, J. A. G., Riches, J. D., Glass, B., Bartonova, V., Zanetti, G., & Kräusslich, H.-G. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903535106 · Cited by 368
“Dimer 1 [PDB3ds5 (24), equivalent to PDB 1a43 (25)] and dimer 2 [PDB1a8o (25)] possess the same basic monomer structure and dimer interface, but exhibit different crossing angles of the dimerising helices.”
BackgroundSelf-citationStructure of the immature HIV-1 capsid in intact virus particles at 8.8 Å resolution
Schur, F. K. M., Hagen, W. J. H., Rumlová, M., Ruml, T., Müller, B., Kräusslich, H.-G., & Briggs, J. A. G. (2015) · Nature · doi:10.1038/nature13838 · Cited by 296
X-ray crystal structures of native HIV-1 capsid protein reveal conformational variability
Gres, A. T., Kirby, K. A., KewalRamani, V. N., Tanner, J. J., Pornillos, O., & Sarafianos, S. G. (2015) · Science · doi:10.1126/science.aaa5936 · Cited by 248
Assembly and Architecture of HIV
Ganser-Pornillos, B. K., Yeager, M., & Pornillos, O. (2012) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4614-0980-9_20 · Cited by 165
“…NMR structures of the isolated CA CTD dimer have identifi ed at least two dimerization modes (side-by-side and domain-swapped, with at least three possible side-by-side confi gurations) (Gamble et al. 1997 ; Worthylake et al. 1999 ; Ivanov et al. 2007 ; Bartonova et al. 2008 ; Byeon et al. 2009 ) .”
Structure of the immature retroviral capsid at 8 Å resolution by cryo-electron microscopy
Bharat, T. A. M., Davey, N. E., Ulbrich, P., Riches, J. D., de Marco, A., Rumlova, M., Sachse, C., Ruml, T., & Briggs, J. A. G. (2012) · Nature · doi:10.1038/nature11169 · Cited by 171
Novel approaches to inhibiting HIV-1 replication
Adamson, C. S., & Freed, E. O. (2010) · Antiviral Research · doi:10.1016/j.antiviral.2009.09.009 · Cited by 144
“Both the CANTD and CACTD play a role in CA hexameric lattice assembly.”
BackgroundInfluentialVirus assembly, allostery and antivirals
Zlotnick, A., & Mukhopadhyay, S. (2010) · Trends in Microbiology · doi:10.1016/j.tim.2010.11.003 · Cited by 142
LEDGINs inhibit late stage HIV-1 replication by modulating integrase multimerization in the virions
Desimmie, B. A., Schrijvers, R., Demeulemeester, J., Borrenberghs, D., Weydert, C., Thys, W., Vets, S., Van Remoortel, B., Hofkens, J., De Rijck, J., et al. (2013) · Retrovirology · doi:10.1186/1742-4690-10-57 · Cited by 139
Crystal structure of an HIV assembly and maturation switch
Wagner, J. M., Zadrozny, K. K., Chrustowicz, J., Purdy, M. D., Yeager, M., Ganser-Pornillos, B. K., & Pornillos, O. (2016) · eLife · doi:10.7554/elife.17063 · Cited by 129
“A fully folded b-turn (but not junction helix) was also observed in the crystal structure of the immature-like dimer form of the CTD (Bartonova et al., 2008).”
BackgroundMethodInfluentialLemke, C. T., Titolo, S., von Schwedler, U., Goudreau, N., Mercier, J.-F., Wardrop, E., Faucher, A.-M., Coulombe, R., Banik, S. S. R., Fader, L., et al. (2012) · Journal of Virology · doi:10.1128/jvi.00493-12 · Cited by 124
“Moreover, several distinct but related CACTD/CACTD dimers have been observed (1, 4, 22, 41), and it is not yet certain how these different dimers are used to connect the CA hexamers and pentamers within authentic viral capsids (22).”
BackgroundHIV-1 Gag Processing Intermediates Trans-dominantly Interfere with HIV-1 Infectivity
Müller, B., Anders, M., Akiyama, H., Welsch, S., Glass, B., Nikovics, K., Clavel, F., Tervo, H.-M., Keppler, O. T., & Kräusslich, H.-G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.027144 · Cited by 106
Self-citationBharat, T. A. M., Castillo Menendez, L. R., Hagen, W. J. H., Lux, V., Igonet, S., Schorb, M., Schur, F. K. M., Kräusslich, H.-G., & Briggs, J. A. G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1401455111 · Cited by 107
“Furthermore, mutations in the region targeted by the capsid assembly inhibitor CAI do not alter assembly of immature particles in vitro or in tissue culture, whereas they completely disrupt assembly of the mature-like lattice (26).”
BackgroundMethodResultInfluentialSelf-citationHIV-1 Maturation: Lessons Learned from Inhibitors
Kleinpeter, A. B., & Freed, E. O. (2020) · Viruses · doi:10.3390/v12090940 · Cited by 119
“Remarkably, crystal structures of these assembly-deficient CA-CTD mutants displayed allosteric changes that were very similar to those induced by CAI when bound to the wild-type CA-CTD [140] (Figure 6C,D).”
BackgroundHIV-1 Capsid Inhibitors as Antiretroviral Agents
Thenin-Houssier, S., & Valente, S. T. (2016) · Current HIV Research · doi:10.2174/1570162x14999160224103555 · Cited by 86
“A series of alanine substitutions of residues mediating strong interaction with CAI have been introduced in CA, and the results suggested an indirect (allosteric) effect of CAI on the assembly of the immature particle, but a direct binding activity in the conserved CTD binding pocket during mature assembly [71].”
BackgroundIn-solution enrichment identifies peptide inhibitors of protein–protein interactions
Touti, F., Gates, Z. P., Bandyopadhyay, A., Lautrette, G., & Pentelute, B. L. (2019) · Nature Chemical Biology · doi:10.1038/s41589-019-0245-2 · Cited by 80
Virus maturation as a new HIV-1 therapeutic target
Adamson, C. S., Salzwedel, K., & Freed, E. O. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903039714 · Cited by 70
“The second effect of CAI is to alter the CACTD–CACTD dimeric interaction that is important for connecting the hexameric lattice [115,116].”
BackgroundRetrovirus maturation-an extraordinary structural transformation
Mattei, S., Schur, F. K., & Briggs, J. A. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.02.008 · Cited by 72
Rotten to the core: antivirals targeting the HIV-1 capsid core
McFadden, W. M., Snyder, A. A., Kirby, K. A., Tedbury, P. R., Raj, M., Wang, Z., & Sarafianos, S. G. (2021) · Retrovirology · doi:10.1186/s12977-021-00583-z · Cited by 74
Unclosed HIV-1 Capsids Suggest a Curled Sheet Model of Assembly
Yu, Z., Dobro, M. J., Woodward, C. L., Levandovsky, A., Danielson, C. M., Sandrin, V., Shi, J., Aiken, C., Zandi, R., Hope, T. J., et al. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.10.006 · Cited by 68
Functional conservation of HIV-1 Gag: implications for rational drug design
Li, G., Verheyen, J., Rhee, S., Voet, A. R. D., Vandamme, A., & Theys, K. (2013) · Retrovirology · doi:10.1186/1742-4690-10-126 · Cited by 63
Antiviral activity of α-helical stapled peptides designed from the HIV-1 capsid dimerization domain
Zhang, H., Curreli, F., Zhang, X., Bhattacharya, S., Waheed, A. A., Cooper, A., Cowburn, D., Freed, E. O., & Debnath, A. K. (2011) · Retrovirology · doi:10.1186/1742-4690-8-28 · Cited by 63
Early Stages of the HIV-1 Capsid Protein Lattice Formation
Grime, J. M. A., & Voth, G. A. (2012) · Biophysical Journal · doi:10.1016/j.bpj.2012.09.007 · Cited by 67
“The trimerof-dimers structure is stabilized by the same native NTDNTD and NTD-CTD contacts found in both pentamers and hexamers, and hence it would be expected that compounds that are experimentally known to disrupt, such as the NTDCTD interactions between adjacent CA proteins (e.g., CA-I (35,36) and CAP-1 (37,38)), w…”
BackgroundCryoET structures of immature HIV Gag reveal six-helix bundle
Mendonça, L., Sun, D., Ning, J., Liu, J., Kotecha, A., Olek, M., Frosio, T., Fu, X., Himes, B. A., Kleinpeter, A. B., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-01999-1 · Cited by 59
Characterization of the In Vitro HIV-1 Capsid Assembly Pathway
Barklis, E., Alfadhli, A., McQuaw, C. M., Yalamuri, S. M., Still, A., Barklis, R. L., Kukull, B., & López, C. S. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.058 · Cited by 60
Chen, B., & Tycko, R. (2010) · Protein Science · doi:10.1002/pro.348 · Cited by 58
Highland, C. M., Tan, A., Ricana, C. L., Briggs, J. A. G., & Dick, R. A. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2220545120 · Cited by 60
Yufenyuy, E. L., & Aiken, C. (2013) · Retrovirology · doi:10.1186/1742-4690-10-29 · Cited by 56
Viral structural proteins as targets for antivirals
Schlicksup, C. J., & Zlotnick, A. (2020) · Current Opinion in Virology · doi:10.1016/j.coviro.2020.07.001 · Cited by 50
Hydrogen/Deuterium Exchange Analysis of HIV-1 Capsid Assembly and Maturation
Monroe, E. B., Kang, S., Kyere, S. K., Li, R., & Prevelige, P. E. (2010) · Structure · doi:10.1016/j.str.2010.08.016 · Cited by 49
“Preventing polyprotein cleavage is the mechanism of action of the clinically proven PR inhibitors, and preventing the structural rearrangement following Gag cleavage is the focus of multiple, small molecule, preclinical, development programs (Bartonova et al., 2008; Li et al., 2003; Sticht et al., 2005; Ternois et al.…”
BackgroundInfluentialStructures of immature EIAV Gag lattices reveal a conserved role for IP6 in lentivirus assembly
Dick, R. A., Xu, C., Morado, D. R., Kravchuk, V., Ricana, C. L., Lyddon, T. D., Broad, A. M., Feathers, J. R., Johnson, M. C., Vogt, V. M., et al. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1008277 · Cited by 48
Machara, A., Lux, V., Kožíšek, M., Šašková, K. G., Štěpánek, O., Kotora, M., Parkan, K., Pávová, M., Glass, B., Sehr, P. A., et al. (2015) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01089 · Cited by 46
Self-citationDendrimers as Potential Inhibitors of the Dimerization of the Capsid Protein of HIV-1
Doménech, R., Abián, O., Bocanegra, R., Correa, J., Sousa‐Herves, A., Riguera, R., Mateu, M. G., Fernández-Megía, E., Velázquez‐Campoy, A., & Neira, J. L. (2010) · Biomacromolecules · doi:10.1021/bm100432x · Cited by 47
Molecular recognition in the human immunodeficiency virus capsid and antiviral design
Bocanegra, R., Rodríguez‐Huete, A., Fuertes, M. A., del Álamo, M., & Mateu, M. G. (2012) · Virus Research · doi:10.1016/j.virusres.2012.06.016 · Cited by 45
An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors
Sun, L., Zhang, X., Xu, S., Huang, T., Song, S. L., Cherukupalli, S., Zhan, P., & Liu, X. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113380 · Cited by 44
New Approaches for Antiviral Targeting of HIV Assembly
Prevelige, P. E. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.03.074 · Cited by 45
“In a series of experiments whose outcome was surprising, using the co-crystal structure as a guide, a series of alanine substitutions were introduced into the CAI binding site on CA.25 As expected, the mutations increased the Kd from ∼1.6 μMas seen for thewild type to values as high as ∼65 μM.”
InfluentialProton-Linked Dimerization of a Retroviral Capsid Protein Initiates Capsid Assembly
Bailey, G. D., Hyun, J., MITRA, A. K., & Kingston, R. L. (2009) · Structure · doi:10.1016/j.str.2009.03.010 · Cited by 40
New Insights into HTLV-1 Particle Structure, Assembly, and Gag-Gag Interactions in Living Cells
Fogarty, K., Zhang, W., Grigsby, I. F., Johnson, J. L., Chen, Y., Mueller, J. D., & Mansky, L. M. (2011) · Viruses · doi:10.3390/v3060770 · Cited by 37
“Cryo-EM, ET and cryo-ET studies on retroviral VLPs (especially HIV-1), in conjunction with the x-ray crystallography and NMR studies of individual domains of Gag proteins [17,116–124] have provided vast structural information on viral structural protein organization in immature and mature particles of various retrovir…”
ResultHIV-1 Gag as an Antiviral Target: Development of Assembly and Maturation Inhibitors
Spearman, P. W. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150902102143 · Cited by 37
Fitness Costs of Mutations at the HIV-1 Capsid Hexamerization Interface
Manocheewa, S., Swain, J. V., Lanxon-Cookson, E. C., Rolland, M., & Mullins, J. I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066065 · Cited by 34
“Other previously studied residues [7,8] are highlighted in cyan-bluepurple color.”
BackgroundResultBreuer, S., Schievink, S. I., Schulte, A., Blankenfeldt, W., Fackler, O., & Geyer, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020033 · Cited by 31
“. Finally, lead inhibitory molecules that target the HIV-1 capsid and prevent assembly of infectious virus particles have been identified and are currently being developed towards therapeutic application by a design approach to achieve cell penetration”
MethodSowd, G. A., & Aiken, C. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009190 · Cited by 32
“To test if viral particle morphology was altered by KO of IPMK or IPPK, particles were classified into 4 morphologies [34,35,37]: (1) aberrant particles having a diffuse, ill-defined core with little obvious electron dense material; (2) eccentric particles containing crescent shaped, envelope adjacent electron dense m…”
Bocanegra, R., Nevot, M., Doménech, R., López‐Font, I., Abián, O., Rodríguez‐Huete, A., Cavasotto, C. N., Velázquez‐Campoy, A., Gómez, J., Martínez, M. Á., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023877 · Cited by 31
“Thus, CAI binding may sterically prevent CTD-NTD heterodimerization, and it may also allosterically alter the CTD dimerization interface, without preventing dimer formation in solution but impairing the native quaternary organization of CA in the capsid lattice [17,20,21].”
BackgroundYeager, M. J. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.04.073 · Cited by 32
The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly
Neira, J. L. (2009) · FEBS Journal · doi:10.1111/j.1742-4658.2009.07314.x · Cited by 32
Rincón, V., Bocanegra, R., Rodríguez‐Huete, A., Rivas, G., & Mateu, M. G. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2010.12.3714 · Cited by 25
“A small peptide (CAI) that was identified by screening a combinatorial library of dodecapeptides binds the CTD and is able to impair the polymerization of CA into capsids by inducing a conformational distortion of CTD and/or sterically impairing self-association of CA (22,38,39).”
BackgroundAnti-HIV-1 Therapeutics: From FDA-approved Drugs to Hypothetical Future Targets
Adamson, C. S., & Freed, E. O. (2009) · Molecular Interventions · doi:10.1124/mi.9.2.5 · Cited by 24
“CAI is a peptide that binds to the CA CTD and interferes with both CA NTD -CA CTD and CA CTD -CA CTD interactions (23, 28).”
BackgroundObr, M., & Schur, F. K. M. (2019) · Advances in virus research · doi:10.1016/bs.aivir.2019.07.008 · Cited by 20
Serrière, J., Fenel, D., Schoehn, G., Gouet, P., & Guillon, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056424 · Cited by 21
“Thus, the presence of extra aminoacids at the N-terminus (our data) or at the C-terminus [59] has no significant incidence on the protein fold and preserves the protein ability to self-assemble.”
BackgroundMartin, J. L., Mendonça, L., Marusinec, R., Zuczek, J., Angert, I., Blower, R. J., Mueller, J. D., Perilla, J. R., Zhang, W., & Mansky, L. M. (2018) · Journal of Virology · doi:10.1128/jvi.00333-18 · Cited by 21
Medicinal Chemistry Strategies of Targeting HIV-1 Capsid Protein for Antiviral Treatment
Xu, S., Sun, L., Huang, B., Liu, X., & Zhan, P. (2020) · Future Medicinal Chemistry · doi:10.4155/fmc-2020-0084 · Cited by 17
Taylor, G. M., Ma, L., Vogt, V. M., & Post, C. B. (2010) · Biochemistry · doi:10.1021/bi902196e · Cited by 14
“Mutagenesis of conserved residues within the CAI binding site of HIV-1 supports the idea that this hydrophobic patch is important in regulating the conformation necessary for virus assembly andmaturation (59).”
BackgroundUrano, E., Kuramochi, N., Ichikawa, R., Murayama, S. Y., Miyauchi, K., Tomoda, H., Takebe, Y., Nermut, M. V., Komano, J. A., & Morikawa, Y. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00299-11 · Cited by 13
“Phage display biopanning has also been employed and has isolated a 12-mer peptide, termed CAI, which binds to HIV-1 CA CTD (50% inhibitory concentration [IC50] 3 to 4 M) and inhibits CA capsid formation in vitro (Kd 15 M) (5, 29, 33).”
MethodPraditwongwan, W., Chuankhayan, P., Saoin, S., Wisitponchai, T., Lee, V. S., Nangola, S., Hong, S. S., Minard, P., Boulanger, P. A., Chen, C., et al. (2014) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-014-9772-9 · Cited by 11
Distinct stabilization of the human T cell leukemia virus type 1 immature Gag lattice
Obr, M., Percipalle, M., Chernikova, D., Yang, H., Thader, A., Pinke, G., Porley, D., Mansky, L. M., Dick, R. A., & Schur, F. K. M. (2024) · Nature Structural & Molecular Biology · doi:10.1038/s41594-024-01390-8 · Cited by 11
Khwaja, A., Galilee, M., Marx, A., & Alian, A. (2016) · Scientific Reports · doi:10.1038/srep24957 · Cited by 9
Manocheewa, S., Mittler, J. E., Samudrala, R., & Mullins, J. I. (2015) · Viruses · doi:10.3390/v7112901 · Cited by 9
“Seventy percent of the mutations were random, the other approximately 20% were alanine substitutions and the rest were the most frequently observed mutations [9,11,14,16,35–39].”
BackgroundGu, Y., Cao, F., Wang, L., Hou, W., Zhang, J., Hew, C., Li, S., Yuan, Y. A., & Xia, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061314 · Cited by 10
“HIV-1 p24 CTD domains from different constructs have been crystallized into several distinct dimerization interfaces: the CTD domain with full affinity displays a side-byside conformation that is primarily stabilized by helix 9 (pdb code 1a43) [15], the CTD domain with a shorter construct displays a similar side-by-si…”
Computational Identification of Novel Amino-Acid Interactions in HIV Gag via Correlated Evolution
Kalinina, O. V., Oberwinkler, H., Glass, B., Kräusslich, H., Russell, R. B., & Briggs, J. A. G. (2012) · PLoS ONE · doi:10.1371/journal.pone.0042468 · Cited by 8
“It has previously been described that mutation of 343L to either S or A prevents formation of the mature CA lattice [19].”
Self-citationNeira, J. L. (2009) · The Scientific World JOURNAL · doi:10.1100/tsw.2009.52 · Cited by 8
“Most interestingly, all those regions contain residues or are close to amino acids that are critical for maintaining the quaternary structure of CAC: Trp184 and Met185 (in the second region)[36], Tyr169 (in the second one)[54], and Leu211 (close to the third region)[54]; further,”
BackgroundInfluentialBocanegra, R., Fuertes, M. A., Rodríguez‐Huete, A., Neira, J. L., & Mateu, M. G. (2015) · Biophysical Journal · doi:10.1016/j.bpj.2014.11.3472 · Cited by 7
“Experimental compounds capable of trapping CTD (within full-length CA or Gag) in other nonproductive conformations have already been identified (18,34,36).”
BackgroundEscrig, J., Marcos‐Alcalde, Í., Domínguez‐Zotes, S., Abia, D., Gómez‐Puertas, P., Valbuena, A., & Mateu, M. G. (2024) · ACS Nano · doi:10.1021/acsnano.4c07948 · Cited by 6
Zhang, D., Xie, L., Xu, X., Li, Y., & Xu, X. (2022) · Microbiology Spectrum · doi:10.1128/spectrum.02663-22 · Cited by 6
“structural information revealed that their binding to CA would disrupt the interface contacts that are required for the assembly of CA (21, 30, 31).”
BackgroundOn the accuracy of unit-cell parameters in protein crystallography
Dauter, Z., & Wlodawer, A. (2015) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s1399004715015503 · Cited by 6
“…2.50 4.5 21.8/28.4 R1 160.912 161.394 49.480 90.32 89.78 119.81 0.320 0.34 0.13 R3 161.153 161.153 49.480 90.00 90.00 120.00 5.4 17.2/28.0 3ds5 (Bartonova et al., 2008) P1 51.359 51.321 51.358 109.20 109.63 109.55 2.40 2.5 22.3/27.0 I1 59.188 59.228 59.478 90.02 89.95 89.95 0.037 0.07 0.08 I41…”
InfluentialZhang, D., Xu, X., Zhou, R., & Fu, Z. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1270258 · Cited by 5
“The binding of a peptide, known as CAI, to a reactive groove located in the CA induces a change in the CA CTD to an assembly-incompetent conformation (Sticht et al., 2005; Ternois et al., 2005; Bartonova et al., 2008), thus making the CAI-binding pocket a potential target for antiviral agents.”
BackgroundDominance Effects of Deleterious and Beneficial Mutations in a Single Gene of the RNA Virus ϕ6
Joseph, S., Peck, K. M., & Burch, C. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097717 · Cited by 8
“Mutations that affect assembly are known to have severe fitness consequences in better-studied viruses like HIV [36,37,38,39,40], and are expected to have similar effects in w6.”
BackgroundZhang, W., Mendonça, L., & Mansky, L. M. (2018) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-981-10-8456-0_8 · Cited by 5
Thermodynamic characterization of the peptide assembly inhibitor binding to HIV-1 capsid protein
Kožíšek, M., Durčák, J., & Konvalinka, J. (2013) · Retrovirology · doi:10.1186/1742-4690-10-s1-p108 · Cited by 1
“The thermodynamics of dissociation of capsid protein dimers in the absence and presence of CAI revealed that the peptide inhibitor did not have any significant effect on protein dimerization.”
MethodInfluentialIn Silico Design: Those Accentuate Assembly of HIV-1 Capsid
Manga, V. (2017) · Novel Approaches in Drug Designing & Development · doi:10.19080/napdd.2017.02.555600 · Cited by 1
“Several small molecule inhibitors like CAP-1, NYAD-1 a peptide inhibitor, bevirimat, a triterpene derivative have been reported to interfere with CA function on binding to the N-terminal domain of CA in both its mature and immature forms [18-25].”
BackgroundCompounds Derived from Birch Trees that Inhibit HIV-1 Replication
Dorr, C. R. (2011) · University of Minnesota Digital Conservancy (University of Minnesota)
Faculty Opinions recommendation of Atomic-level modelling of the HIV capsid.
Columbus, L. M., & Dewald, A. H. (2011) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.8136959.10321054
BindingDB Entry 50015611: An insight on medicinal aspects of novel HIV-1 capsid protein inhibitors.
BindingDB (2023) · UC San Diego · doi:10.7270/q21z48bw
Metadata
- Authors
- Bartonova, V., Igonet, S., Sticht, J., Glass, B., Habermann, A., Vaney, M.-C., Sehr, P., Lewis, J., Rey, F. A., & Kraüsslich, H.-G.
- Affiliations
- Centre National de la Recherche Scientifique (FR)
- University Hospital Heidelberg (DE)
- European Molecular Biology Laboratory (DE)
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2008-11
- Volume
- 283
- Issue
- 46
- Pages
- 32024-32033
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2024563086
- Cited by
- 76
- References
- 38
- Citations by year
- 2024: 2 · 2023: 3 · 2022: 1 · 2021: 4 · 2020: 5 · 2019: 2 · 2018: 2 · 2017: 1 · 2016: 5 · 2015: 6 · 2014: 4 · 2013: 7 · 2012: 7
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4344 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DORA PSI (Paul Scherrer Institute) (submittedVersion, cc-by)
- HAL (submittedVersion)
- Funders
- European Commission (FP7 program)
- Deutsche Forschungsgemeinschaft (SFB544)
- European Synchrotron Radiation Facility
- Topics
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › HIV/AIDS drug development and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
- Keywords
- HIV-1 capsid protein, capsid assembly, allosteric effects, binding site mutations, capsid assembly inhibitors, infectivity
- MeSH terms
- Amino Acid Sequence, Binding Sites, Capsid, Cell Line, Humans, Microscopy, Electron, Models, Molecular, Molecular Sequence Data, Mutation, Peptides, HIV-1, Sequence Alignment, Conserved Sequence, Crystallography, X-Ray, Virus Assembly, Protein Structure, Quaternary, Capsid Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.